Coronavirus COVID-19 Medical Science Plays

[exotic]

$MYMX CoVid-19 NEWS Mymetics and Baylor College of Medicine start Research Collaboration for Virosome-based Covid-19 Vaccines
ACCESSWIRE FOLLOW

(MYMX: LOW FLOAT STOCK STOCK AND STILL CHEAP)

Mymetics has started a Covid-19 vaccine development project based on Mymetics' virosome vaccine carrier platform, which will evaluate different rationally designed SARS-CoV-2 antigens for an effective and safe virosome-based Covid-19 vaccine
Baylor College of Medicine in Texas has developed SARS-CoV and SARS-CoV-2 recombinant proteins and has extensive expertise developing protein-based vaccines from discovery through clinical testing
Baylor and Mymetics will collaborate to evaluate the Baylor SARS recombinant protein antigens linked to Mymetics' virisomes in preclinical studies with the aim to identify and select the most efficacious and safe formulations to take forward a virosome-based COVID-19 vaccine through product and clinical development


https://www.mymetics.com/media-center/mymetics/

https://www.benzinga.com/pressreleases/20/05/ac16053140/mymetics-and-baylor-college-of-medicine-start-research-collaboration-for-virosome-based-covid-19


AND

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155693926